Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00375219
Status:
COMPLETED
Last Update Posted:
2021-11-15
First Post:
2006-09-08
Brief Title:
Homoharringtonine Omacetaxine Mepesuccinate in Treating Patients With Chronic Myeloid Leukemia CML With the T315I BCR-ABL Gene Mutation
Sponsor:
Teva Branded Pharmaceutical Products RD Inc
Organization:
Teva Branded Pharmaceutical Products RD Inc